Posted on 16/01/2024
17/01/2024 | Rayner, a global leader in products for cataract surgery, headquartered in Worthing, UK, announces today that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines. Throughout its 114-year history, Rayner has been at the forefront of innovation in ophthalmology and
Posted on 21/12/2023
Rayner, a global manufacturer of products for cataract surgery, is delighted to have scored within the top 17% of companies in the 2023 EcoVadis ratings. EcoVadis is the world’s largest provider of business sustainability ratings, assessing a global network of over 100,000 companies. The first of Rayner’s assessments in 2022 resulted in a respectable Bronze
Posted on 14/12/2023
Rayner, a global manufacturer of products for cataract surgery headquartered in Worthing, UK, has introduced a number of beehives to their site to contribute towards their environmental and social responsibility goals for this year. Honeybees are known to be vital in pollinating food sources and wild plants, supporting biodiversity and maintaining the ecosystem, as well
Posted on 4/09/2023
Worthing, United Kingdom – Rayner, a pioneering leader in ophthalmic innovation, is thrilled to announce a series of ground-breaking updates to its digital platforms, RayPRO and Peer2Peer, set to redefine patient-reported outcome measures (PROMs) and elevate clinical ophthalmic education. Attendees of the ESCRS 2023 congress are invited to explore these transformative advancements at booth B303.
Posted on 11/08/2023
Worthing, United Kingdom – August 11, 2023: Rayner, a global ophthalmic leader in Devices, Drugs and Digital, is pleased to announce the successful completion of the first implantations in two pivotal market access studies in China and the USA. In April, Rayner received approval from the People’s Republic of China’s Ministry of Science and Technology
Posted on 25/07/2023
Rayner, a renowned global leader in innovative ophthalmic solutions and the pioneering manufacturer of the world’s first intraocular lens (IOL) in 1949, proudly announces a significant achievement in their ongoing dedication to improving vision. Last month, the company celebrates the successful implantation of their 4 millionth RayOne IOL, underscoring their commitment to advancing eye care
Posted on 28/04/2023
Worthing, UK, 24 April 2023 – Rayner, a global leader in Drugs, Devices and Digital ophthalmic solutions, announced today that Geoff Allan has been appointed as Chief Financial Officer (CFO) effective from 3 May 2023. In his new role, Geoff will be responsible for overseeing global financial, legal and HR divisions across the entire Rayner
Posted on 17/04/2023
Rayner announces partnership with Evertreen to promote sustainability and environmental conservation ahead of National Earth Day. The partnership aims to address climate change and promote biodiversity through tree planting initiatives. Rayner has pledged to gift each of its 577 employees two trees through Evertreen to plant in various regions around the world to contribute to
Posted on 10/01/2023
The first seven episodes of ‘Peer2Peer: The Podcast’ are now available, featuring Dr Lisa Nijm (USA), Dr Paul Singh (USA), Dr Stefanie Schmickler (Germany), Dr Josefina Botta (Argentina), Dr Karl Stonecipher (USA), Professor Graham Barrett (Australia), Mr Paul Rosen (UK), Mr Allon Barsam (UK), Mr Andrew Turnbull (UK), Dr Eric Donnenfeld (USA) and Dr Jerry
Posted on 16/09/2022
16 September 2022. Worthing, United Kingdom – Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, today announced that the world’s first implantations of RayOne EMV Toric had been performed by two highly respected surgeons from the UK. RayOne EMV Toric is the awaited toric variant of Rayner’s popular RayOne